Christine Woods is an experienced professional in the field of regulatory affairs, currently serving as Vice President at Conventus Biomedical Solutions, Inc. since March 2019, where responsibilities encompass various aspects of drug development, including oncology, gastroenterology, dermatology, neurology, and medical devices. Prior to this role, Christine held positions such as Sr. Director at Conventus Biomedical Solutions, Global Regulatory Lead at Puma Biotechnology, and North American Regulatory Lead at Janssen Inc., building a robust background in both branded and generic drug development. Early career experiences include significant roles at Watson Pharmaceuticals, Pain Therapeutics, and Aradigm Corporation, with a total of over three decades in regulatory affairs beginning with a foundation in analytical chemistry. Christine holds a Bachelor's degree in Biology/Chemistry from Dominican University of California and a Master's degree in Toxicology from San Jose State University.